The potential reassessment of cannabinoids, particularly at the federal level, is generating considerable anticipation within the industry. A shift away from Schedule I status, often viewed as outdated and hindering https://social-lyft.com/story10770198/cannabinoid-rescheduling-a-expansion-catalyst